DE68916651D1 - Heilmittel zur behandlung von toxoplasmose. - Google Patents

Heilmittel zur behandlung von toxoplasmose.

Info

Publication number
DE68916651D1
DE68916651D1 DE68916651T DE68916651T DE68916651D1 DE 68916651 D1 DE68916651 D1 DE 68916651D1 DE 68916651 T DE68916651 T DE 68916651T DE 68916651 T DE68916651 T DE 68916651T DE 68916651 D1 DE68916651 D1 DE 68916651D1
Authority
DE
Germany
Prior art keywords
toxoplasmosis
medicines
prophylaxis
animal
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68916651T
Other languages
English (en)
Other versions
DE68916651T2 (de
Inventor
Alan Hudson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE68916651D1 publication Critical patent/DE68916651D1/de
Application granted granted Critical
Publication of DE68916651T2 publication Critical patent/DE68916651T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE68916651T 1989-09-22 1989-10-26 Heilmittel zur behandlung von toxoplasmose. Expired - Lifetime DE68916651T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898921516A GB8921516D0 (en) 1989-09-22 1989-09-22 Medicaments
PCT/GB1989/001286 WO1991004021A1 (en) 1989-09-22 1989-10-26 Medicaments for the treatment of toxoplasmosis

Publications (2)

Publication Number Publication Date
DE68916651D1 true DE68916651D1 (de) 1994-08-11
DE68916651T2 DE68916651T2 (de) 1995-02-16

Family

ID=10663513

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68916651T Expired - Lifetime DE68916651T2 (de) 1989-09-22 1989-10-26 Heilmittel zur behandlung von toxoplasmose.

Country Status (17)

Country Link
EP (1) EP0445141B1 (de)
JP (1) JP2810746B2 (de)
KR (1) KR920700626A (de)
AT (1) ATE108063T1 (de)
AU (1) AU628422B2 (de)
CA (1) CA2001568C (de)
DE (1) DE68916651T2 (de)
DK (1) DK175716B1 (de)
GB (1) GB8921516D0 (de)
HU (1) HU207942B (de)
IE (1) IE66153B1 (de)
MC (1) MC2142A1 (de)
MW (1) MW1291A1 (de)
PH (1) PH27250A (de)
SG (1) SG28346G (de)
WO (1) WO1991004021A1 (de)
ZA (1) ZA898146B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9224739D0 (en) 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
WO2010023686A2 (en) * 2008-08-29 2010-03-04 Matrix Laboratories Limited Crystalline form of 2-chloro-3-[4-(4-chlorophenyl) cyclohexyl] [1,4]naphthoquinone, process for the same and use for producing 2-[4-(4-chlorophenyl)cyclohexyl]-3- hydroxy- 1,4- naphthoquinone
US9169232B2 (en) * 2011-09-16 2015-10-27 Alkem Laboratories Limited 3-(5-methyl-2-oxo-l, 3-dioxol-4-yl) methyloxy-2-trans-[(4-chloro phenyl) cyclohexyl][1,4]naphthaquinone-atovaquone prodrug
CN104474416A (zh) * 2014-11-03 2015-04-01 青岛绿曼生物工程有限公司 治疗猪弓形体病的复方蜂胶组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
DE68928964T2 (de) * 1988-08-16 1999-07-29 Wellcome Found Neue Naphthochinone und ihre Anwendung als Arzneimittel

Also Published As

Publication number Publication date
CA2001568A1 (en) 1991-03-22
AU628422B2 (en) 1992-09-17
DK93091D0 (da) 1991-05-16
ATE108063T1 (de) 1994-07-15
JPH04504107A (ja) 1992-07-23
GB8921516D0 (en) 1989-11-08
SG28346G (en) 1995-09-18
PH27250A (en) 1993-05-04
EP0445141A1 (de) 1991-09-11
KR920700626A (ko) 1992-08-10
HUT57040A (en) 1991-11-28
CA2001568C (en) 1998-05-12
DK93091A (da) 1991-06-28
DK175716B1 (da) 2005-01-31
ZA898146B (en) 1991-06-26
MW1291A1 (en) 1991-11-13
JP2810746B2 (ja) 1998-10-15
IE893451A1 (en) 1991-03-27
MC2142A1 (fr) 1992-02-18
DE68916651T2 (de) 1995-02-16
HU896916D0 (en) 1991-08-28
EP0445141B1 (de) 1994-07-06
AU4519189A (en) 1991-04-18
HU207942B (en) 1993-07-28
WO1991004021A1 (en) 1991-04-04
IE66153B1 (en) 1995-12-13

Similar Documents

Publication Publication Date Title
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
DE69025271T2 (de) Pharmazeutische Zubereitungen mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen
ATE198550T1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
DE68916651D1 (de) Heilmittel zur behandlung von toxoplasmose.
DE69125940D1 (de) Pharmazeutische zusammensetzungen die 5-difluormethoxy-2-[3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten
DE68916443T2 (de) Arzneimittel zur behandlung von kryptosporidiose.
DE69312297T2 (de) Verwendung von 2-[4-(-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphtoquinon zur behandlung von krebs
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
GEP19970834B (en) 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
DE60113895D1 (de) Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose
RU93052444A (ru) Лекарственный препарат бан

Legal Events

Date Code Title Description
8364 No opposition during term of opposition